Skip to main content

Table 1 Clinical and pathological data

From: Non-grasping en bloc mediastinal lymph node dissection for video-assisted thoracoscopic lung cancer surgery

Variant

N (n = 402)

Procedure

 

Left upper lobectomy

96 (23.9%)

Left lower lobectomy

67 (16.7%)

Right upper lobectomy

126 (31.3%)

Right middle lobectomy

35 (8.7%)

Right lower lobectomy

66 (16.4%)

Right upper and middle lobectomy

3 (0.7%)

Right middle and lower lobectomy

9 (2.3%)

Pathology

 

Adenocarcinoma

306 (76.1%)

Squamous carcinoma

78 (19.4%)

Adenosquamous carcinoma

12 (3.0%)

Carcinoid

2 (0.5%)

Othersa

4 (1.0%)

Pathological stage

 

Ia

115 (28.6%)

Ib

207 (51.5%)

IIa

31 (7.7%)

IIIa

49 (12.2%)

Complications

 

Pneumonia

26 (6.5%)

Air leakage >7 daysb

12 (3.0%)

Drainage >7 daysc

7 (1.7%)

Arrhythmia

5 (1.3%)

Asthma

3 (0.7%)

Chylothorax

3 (0.7%)

Recurrent laryngeal nerve paralysis

3 (0.7%)

Pneumonia + Drainage >7 days

2 (0.5%)

Pulmonary embolism

2 (0.5%)

Postoperative hemorrhage

2 (0.5%)

Othersd

5 (1.3%)

  1. aEach case of large cell neuroendocrine carcinoma, clear-cell carcinoma, lymphoepitheloid carcinoma, and compound carcinoma (small cell and squamous cell); bProlonged air leakage accompanied with or without persisted drainage; cProlonged drainage only attributed to large amount of daily drainage; dEach case of mental symptom, deep venous thrombosis, wound infection, bronchopleural fistula, and hepatic dysfunction.